Earnings summaries and quarterly performance for Beneficient.
Executive leadership at Beneficient.
Board of directors at Beneficient.
Research analysts who have asked questions during Beneficient earnings calls.
Recent press releases and 8-K filings for BENF.
Beneficient Receives Final Court Approval for GWG Litigation Settlement
BENF
Legal Proceedings
- Beneficient announced on January 21, 2026, that the United States District Court for the Northern District of Texas granted final approval to the settlement agreement resolving all claims related to GWG Holdings, Inc. against the Company, its subsidiaries, and their current and former directors and officers.
- This final approval fully and finally resolves all GWG Litigation against the Beneficient Parties without any admission of fault, liability, or wrongdoing.
- The settlement was for a sum within applicable insurance policy limits and had previously been approved by the Bankruptcy Court in June 2025.
- Other outstanding GWG-related claims against parties other than Beneficient remain, including certain claims against entities related to Beneficient’s former CEO, to whom Beneficient may owe indemnification obligations.
Jan 21, 2026, 12:15 PM
Beneficient Announces Final Court Approval of GWG Litigation Settlement
BENF
Legal Proceedings
- The United States District Court for the Northern District of Texas has approved the settlement agreement resolving all claims in the GWG Litigation against Beneficient, its subsidiaries, and their current and former directors and officers.
- This settlement fully and finally resolves all GWG Litigation against the Beneficient Parties, with the sum falling within applicable insurance policy limits and without any admission of fault or liability by the company.
- Interim Chief Executive Officer James Silk stated that the approval allows Beneficient to focus on executing its business strategy and creating value for shareholders.
- While claims against Beneficient are resolved, other outstanding GWG-related claims against entities related to Beneficient's former CEO remain, for which Beneficient may owe certain indemnification obligations.
Jan 21, 2026, 12:00 PM
Beneficient Announces Early Debt Payoff
BENF
Debt Issuance
- Beneficient completed the early repayment of approximately $27.5 million in loans on January 12, 2026, about ten months prior to the original maturity date of October 19, 2026.
- The company still owes $1.66 million to Hicks Holdings for deferred interest and fees, which it anticipates paying over time on mutually agreed terms.
- This early repayment aims to strengthen Beneficient's balance sheet, reduce leverage, and improve financial flexibility.
Jan 20, 2026, 12:15 PM
Beneficient Announces Early Repayment of Debt
BENF
Debt Issuance
- Beneficient (Nasdaq: BENF) has completed the repayment of approximately $27.5 million in loans to a Texas state bank.
- This repayment was made approximately ten months prior to the original maturity date.
- The company still owes approximately $1.66 million to Hicks Holdings for deferred interest and fees, which it anticipates paying over time.
- This early repayment aims to strengthen Beneficient's balance sheet, reduce leverage, and improve financial flexibility.
Jan 20, 2026, 12:00 PM
Beneficient Regains Full Compliance with Nasdaq Listing Requirements
BENF
Delisting/Listing Issues
- Beneficient (BENF) announced on January 5, 2026, that it had regained full compliance with The Nasdaq Capital Market’s listing requirements.
- The company received notification on January 2, 2026, from Nasdaq that it had satisfied the minimum bid price requirement (Rule 5550(a)(2)) and the continued listing requirements for warrants (Rule 5560(a)).
Jan 5, 2026, 12:15 PM
Beneficient Regains Full Nasdaq Listing Compliance
BENF
Delisting/Listing Issues
- Beneficient (Nasdaq: BENF) announced on January 5, 2026, that it has regained full compliance with The Nasdaq Capital Market's listing requirements.
- The company was notified by Nasdaq on January 2, 2026, that it met the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
- Beneficient also regained compliance with the continued listing requirements for warrants under Nasdaq Listing Rule 5560(a).
Jan 5, 2026, 12:00 PM
Beneficient Announces 1-for-8 Reverse Stock Split
BENF
Delisting/Listing Issues
Proxy Vote Outcomes
- Beneficient announced a 1-for-8 reverse stock split of its Class A and Class B common stock, which was approved by stockholders on December 1, 2025.
- The reverse stock split is intended to regain compliance with Nasdaq's minimum bid price requirement.
- The Class A Common Stock will begin trading on a split-adjusted basis on December 15, 2025, under the existing symbol "BENF".
- As a result of the split, the number of outstanding Class A Common Stock shares is expected to decrease from approximately 110,758,536 to 13,844,817, and Class B Common Stock shares from approximately 239,256 to 29,907.
Dec 11, 2025, 12:45 PM
Beneficient Announces Reverse Stock Split
BENF
Delisting/Listing Issues
- Beneficient (Nasdaq: BENF) announced a 1-for-8 reverse stock split of its Class A and Class B common stock, with trading on a split-adjusted basis commencing December 15, 2025.
- The reverse stock split is intended to enable Beneficient to regain compliance with Nasdaq's minimum bid price requirement.
- As a result, the number of issued and outstanding Class A Common Stock is expected to decrease from approximately 110,758,536 pre-split to 13,844,817 post-split, and Class B Common Stock from 239,256 to 29,907.
- The number of authorized shares will also be proportionally reduced, with Class A Common Stock decreasing from 5,000,000,000 to 625,000,000 and Class B Common Stock from 250,000 to 31,250.
Dec 11, 2025, 12:30 PM
Beneficient Stockholders Approve Reverse Stock Split
BENF
Proxy Vote Outcomes
Delisting/Listing Issues
- Beneficient (BENF) stockholders approved a reverse stock split proposal at a special meeting.
- The approved reverse stock split allows for a ratio in the range of one-for-five to one-for-one hundred, with the exact ratio to be determined by the Board of Directors.
- A quorum was present for the meeting, with 110,758,036 shares of Class A common stock and 239,257 shares of Class B common stock entitled to vote as of the October 27, 2025 record date.
- An adjournment proposal was also approved, but the meeting was not adjourned to a later date as the reverse stock split proposal passed.
Dec 1, 2025, 3:00 PM
Beneficient Stockholders Approve Reverse Stock Split Proposal
BENF
Proxy Vote Outcomes
Delisting/Listing Issues
- A special meeting of Beneficient stockholders was held on December 7, 2025, with the record date for voting set as October 27, 2025.
- Stockholders voted on a proposal for a reverse stock split of common stock at a ratio in the range of one-for-five to one-for-one hundred, with the exact ratio and timing to be determined by the board of directors.
- Based on a preliminary count, stockholders approved both the reverse stock split proposal and an adjournment proposal. However, an adjournment of the meeting was not necessary due to the approval of the reverse stock split proposal.
Dec 1, 2025, 3:00 PM
Quarterly earnings call transcripts for Beneficient.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more